Skip to main content

Month: June 2025

OneMedNet Announces Additional $3.7 Million of Funding in Private Placement Transactions and Approximately $11 Million in Reductions in Liabilities

MINNEAPOLIS, June 24, 2025 (GLOBE NEWSWIRE) — OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading provider of regulatory-grade imaging Real-World Data (iRWD), today announced that it has entered into agreements with accredited investors in private placement transactions at $0.42 per share of common stock that resulted in gross proceeds of approximately $3.7 million, before deducting fees and expenses payable by the Company. Certain Company’s founders and directors participated in the private placement transactions. OneMedNet intends to use the proceeds of these private placements for working capital and general corporate purposes. The private placements closed on or about June 19, 2025, and the price per share of common stock sold in these private placements exceeded the minimum price requirement under...

Continue reading

Clearmind Medicine Joins Forces with Leading US Political Firm to Promote Psychedelic Therapeutics

Vancouver, Canada, June 24, 2025 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, announced earlier this month it has engaged a prominent government and political affairs consulting and lobbying firm to support its mission of advancing psychedelic-based treatments. As psychedelics gain traction in the pharmaceutical industry for their potential to treat conditions such as Post-Traumatic Stress Disorder (PTSD) and other mental health disorders, Clearmind recognizes the importance of navigating complex regulatory landscapes and fostering greater acceptance among policymakers in the U.S.. The company’s partnered with the...

Continue reading

InnovAge PACE Sponsors Documentary Spotlighting National Crisis in Family Caregiving

PBS “Caregiving” Documentary, featuring Actor Bradley Cooper, Premieres Tonight DENVER, June 24, 2025 (GLOBE NEWSWIRE) — InnovAge, the nation’s largest provider of the Program of All-inclusive Care for the Elderly (PACE) based on participants served, announced today its sponsorship of the new PBS documentary Caregiving, airing tonight, June 24, at 9pm ET on PBS. Executive produced by and featuring Grammy-winning actor Bradley Cooper, and narrated by Emmy-winning actor Uzo Aduba, the film offers an in-depth look at the challenges and triumphs of America’s caregivers. “At InnovAge, our mission is rooted in supporting seniors and those who care for them,” says InnovAge CEO Patrick Blair. “Caregiving demonstrates the critical role caregivers play across the country. We are proud to help bring these powerful stories to light as we work...

Continue reading

SharpLink Gaming Expands ETH Treasury Holdings to 188,478

MINNEAPOLIS, MN, June 24, 2025 (GLOBE NEWSWIRE) — SharpLink Gaming, Inc. (Nasdaq: SBET) (“SharpLink” or the “Company”), the largest publicly traded holder of Ethereum (“ETH”) in the world, today announced that the Company has strategically increased its total holdings of ETH to 188,478 ETH, acquiring an additional 12,207 ETH for $30,674,829 (inclusive of fees and expenses) at an average price of $2,513 per ETH (inclusive of fees and expenses) during the period June 16, 2025 through June 20, 2025. In addition, during that same period SharpLink raised approximately $27.7 million in net proceeds through its At-The-Market facility (“ATM”) selling 2,547,180 shares of the Company’s common stock. A majority of the ATM proceeds from these sales will be used to further increase SharpLink’s ETH treasury holdings. As of June 20, 2025, 100%...

Continue reading

Following the Resumption of Federal Collection Activities in May, Nearly One in Three Federal Student Loan Borrowers Find Themselves at Risk for Default

New TransUnion analysis finds record number of borrowers 90 or more days past due, with many only weeks away from potentially defaulting CHICAGO, June 24, 2025 (GLOBE NEWSWIRE) — Less than two months since the U.S. Department of Education resumed collections activities among defaulted federal student loan borrowers, new research from TransUnion (NYSE: TRU) reveals that the number of consumers delinquent on student loans and at risk for entering default continues to climb. The analysis will be featured in a new TransUnion webinar titled Market Update: Student Loan Repayment Impacts on June 26th. The updated analysis found that as of April 2025, the latest month for which data are available, 31.0% of federal student loan borrowers with a payment due are 90 days or more past due (90+ DPD) as reported by their servicer.1 This represents...

Continue reading

Aardvark Therapeutics to Join Prader-Willi Syndrome Community at the 2025 United in Hope Conference

SAN DIEGO, June 24, 2025 (GLOBE NEWSWIRE) — Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases, today announced that members of its team will join the Prader-Willi syndrome (PWS) community at the 2025 United in Hope Conference, taking place June 24 to 28 in Phoenix, Arizona. “It’s an honor to stand alongside the families, advocates, scientists and clinicians who are working to transform the lives of those affected by PWS,” said Dr. Tien Lee, Chief Executive Officer of Aardvark Therapeutics. “The United in Hope Conference is a powerful reflection of the passion, resilience and shared purpose that drive our mission. We’re proud to contribute to the...

Continue reading

BriaCell Announces Positive Recommendation from Data Safety Monitoring Board for Pivotal Phase 3 Study in Metastatic Breast Cancer

Independent DSMB identifies no safety concerns, and recommends continuation of BriaCell’s pivotal Phase 3 study of Bria-IMT™ plus immune check point inhibitor Review marks third consecutive positive recommendation by DSMB Study is being conducted under FDA Fast Track DesignationPHILADELPHIA and VANCOUVER, British Columbia, June 24, 2025 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company developing novel immunotherapies to transform cancer care, is pleased to report that the independent Data Safety Monitoring Board (DSMB) has completed its third scheduled safety data review of BriaCell’s pivotal Phase 3 study of Bria-IMT plus immune checkpoint inhibitor (CPI) in metastatic breast cancer (NCT06072612). Following its...

Continue reading

Endeavour Silver Amends and Restates Project Loan Credit Facility to Include Additional Credit Facility of US$15 Million

VANCOUVER, British Columbia, June 24, 2025 (GLOBE NEWSWIRE) —  Endeavour Silver Corp. (“Endeavour” or the “Company”) (NYSE: EXK; TSX: EDR) is pleased to announce that its wholly-owned subsidiary, Terronera Precious Metals, S.A. de C.V. (Terronera) has amended and restated the previously announced senior secured debt facility (the “Credit Facility”) with ING Capital LLC (together with ING Bank N.V.) and Societe Generale acting as Joint Lead Arrangers. The Credit Facility was announced by press release on October 10, 2023. Among other things, the Credit Facility was amended and restated to increase the principal amount of up to $120,000,000 by an additional $15,000,000, bringing the aggregate principal amount up to $135,000,000. Proceeds from the Credit Facility will be used towards completing commissioning at the Company’s Terronera...

Continue reading

ZenaTech Expands Drone as a Service (DaaS) for Government and Defense, Signing an Offer to Acquire a Virginia-Headquartered Tri-State Land Survey and Engineering Firm Serving Major US Federal Clients

VANCOUVER, British Columbia, June 24, 2025 (GLOBE NEWSWIRE) — ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) (“ZenaTech”), a technology company specializing in AI (Artificial Intelligence) drones, Drone as a Service (DaaS), enterprise SaaS, and Quantum Computing solutions, announces it has signed an offer to acquire a Virginia-headquartered land survey and civil engineering firm with operations in three states and expertise serving major US federal government agencies and regional infrastructure programs. Upon completion, this acquisition would mark ZenaTech’s first entry into the states of Virginia, North Carolina, and South Carolina, accelerating the Company’s expansion across the Southeast region of the US. “This acquisition reinforces our DaaS business model expansion objectives to provide drone innovation supporting...

Continue reading

Advanced Flower Capital Schedules Earnings Release and Conference Call for the Second Quarter Ending June 30, 2025

WEST PALM BEACH, Fla., June 24, 2025 (GLOBE NEWSWIRE) — Advanced Flower Capital Inc. (Nasdaq: AFCG) (“AFC”) today announced that it will release its financial results for the second quarter ending June 30, 2025 on Thursday, August 14th, 2025 before market open. Management will review AFC’s financial results at 10:00 am ET via webcast available on the Investor Relations section of AFC’s website found here AFC — Investor Relations. Participants are also invited to access the conference call by registering in advance at this link. A replay will be available one hour after the event. AFC distributes its earnings releases via its website and email lists. Those interested in receiving firm updates by email can sign up for them here. About Advanced Flower Capital Inc. Advanced Flower Capital Inc. (Nasdaq: AFCG) is a leading commercial...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.